# A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects

> **NCT04104503** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lu AF11167
- **DRUG:** [14C]-Lu AF11167
- **DRUG:** Lu AF11167 MR tablet prototype formulation selected from part A or 1 mg modified release tablet (reference formulation)

## Key facts

- **NCT ID:** NCT04104503
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-17
- **Primary completion:** 2020-04-09
- **Final completion:** 2020-04-09
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04104503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04104503, "A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04104503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*